dr. guru sonpavde on bladder cancer | dana-farber cancer institute
Published 4 years ago • 1.1K plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:02
dana-farber cancer institute: guru sonpavde, md at asco gu21 (bladder cancer)
-
2:01
dr. guru sonpavde, dana-farber cancer institute, usa
-
2:07
dana-farber cancer institute: guru sonpavde, md (bladder cancer research at asco gu21)
-
1:17
bladder cancer research: metabolomic plasma profiling | dana-farber cancer institute
-
1:25
bladder cancer research: immunotherapy outcomes | dana-farber cancer institute
-
1:49
dana-farber cancer institute: guru sonpavde, md at asco gu21 (urothelial carcinoma)
-
1:23
bladder cancer research at esmo 2021
-
6:57
dr. guru sonpavde
-
4:18
dr. guru sonpavde on nivolumab, gem-cis fda approval and role in treating metastatic bladder cancer
-
3:31
the use of immunotherapy as a first-line therapy for bladder cancer
-
2:30
new treatments for bladder cancer patients
-
1:26
dr. sonpavde on remaining questions with immunotherapy in bladder cancer
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
1:10
dr. sonpavde on the potential for neoadjuvant immunotherapy in bladder cancer
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
2:10
highlights in bladder cancer
-
0:53
dr. sonpavde on immunotherapy plus chemotherapy in bladder cancer
-
29:43
survivorship series: bladder cancer survivorship
-
1:47
current and upcoming clinical trials in bladder cancer
-
1:24
dr. sonpavde on neoadjuvant immunotherapy in bladder cancer
-
0:50
dr. sonpavde on immunotherapy combination studies in urothelial carcinoma